Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sophie Vandervennet"'
Autor:
Michel Delforge, Marie-Christiane Vekemans, Julien Depaus, Nathalie Meuleman, Ann Van de Velde, Isabelle Vande Broek, Sophie Vandervennet, Sandra Van Hoorenbeeck, Evelien Moorkens, Danielle Strens, Joris Diels, Francesca Ghilotti, Benjamin Haefliger, Sander Dalhuisen, William Deraedt, Sébastien Anguille
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e813 (2022)
Externí odkaz:
https://doaj.org/article/17207826678541428346ed53dedf3abe
Autor:
Michel Delforge, Marie-Christiane Vekemans, Sébastien Anguille, Julien Depaus, Nathalie Meuleman, Ann Van de Velde, Isabelle Vande Broek, Danielle Strens, Sandra Van Hoorenbeeck, Evelien Moorkens, Joris Diels, Francesca Ghilotti, Sander Dalhuisen, Sophie Vandervennet
Publikováno v:
Transplantation and Cellular Therapy. 28:S6-S7
Autor:
Francesca Ghilotti, Sophie Vandervennet, Michel Delforge, Evelien J Moorkens, Danielle Strens, Marie-Christiane Vekemans, Isabelle Vande Broek, Joris Diels, Ann Van de Velde, Sébastien Anguille, Sandra Van Hoorenbeeck, Julien Depaus, Nathalie Meuleman, Sander Dalhuisen
Publikováno v:
Blood. 138:4075-4075
Background: With the advent of immunomodulatory agents (IMiDs), proteasome inhibitors (PIs) and, more recently, anti-CD38 monoclonal antibodies (mAbs), prognosis of patients with multiple myeloma (MM) has improved considerably. Unfortunately, even wi